Scott Chan

Scott Chan moved from China to the U.S. with family at the age of ten. He passed the rigorous entrance exam and attended the merit-based Stuyvesant High School, widely held to be best public school in New York City. He earned undergraduate degrees from New York University followed by an MBA degree from the Zicklin School of Business at Baruch College.

Shortly thereafter Scott partnered with Dr. Stephen Leeb on numerous financial publications. Today, he serves as the lead analyst for Real World Investing and The Complete Investor.

Mr. Chan is an avid baseball fan and enjoys outdoor activities in his spare time. A multicultural person, he reads Chinese and speaks fluent Mandarin and Cantonese Chinese.

Analyst Articles

Jazz Pharmaceuticals (NASDAQ: JAZZ) has finally caught some positive momentum, gaining about 10% during the week. CEO Bruce Cozadd gave a strong presentation at the annual J.P. Morgan Healthcare Conference, which helped to awaken buying interest in the stock. Good Results Confirmed Jazz confirmed its 2017 revenue guidance, expected to… Read More

Yesterday AngioDynamics (NASDAQ: ANGO) reported earnings (adjusted for one-time gains and losses) of $0.16 per share for its second fiscal quarter ended on November 30, 2016. The result missed analysts’ consensus expectation of $0.17 per share. Revenue also missed expectation: $86.7 million versus the $87.8 million expected. Due to the… Read More

Last Friday afternoon, as I noted in the comment section on our website, news broke that Home Depot is considering making a bid for XPO Logistics (NYSE: XPO). The news was a welcome early Christmas gift for shareholders, as the stock shot up to $90 a share. Home Depot and… Read More

Share of AAR Corp. (NYSE: AIR) reached an all-time high yesterday. But after the company reported somewhat soft results in the early evening, the stock fell. AAR reported quarterly revenue of $449.7 million, in line with The Street’s expectation, but earnings per share was a little light. Adjusted EPS was… Read More

IQVIA (NYSE: IQV) has launched a new commercial technology called Orchestrated Customer Engagement (OCE). The new enterprise software is described as a “transformative technology for life sciences commercial operations” that “can result in increased productivity, better alignment and communication between former silos in pharmaceutical commercial operations, higher customer satisfaction among… Read More

Synchrony Financial (NYSE: SYF) has rallied above $37 a share thanks largely to progression of the tax bill in Congress. Both the House and the Senate have passed a tax bill, greatly raising the probability that we could have a new tax law perhaps as early as before the end… Read More

Last week, we added IQVIA Holdings (NYSE: IQV) to our portfolio. The company was previously known as QuintilesIMS until November 15. On that date, the company changed its name and stock symbol to their present form. The company itself was formed via merger in 2016 between Quintiles and IMS Health,… Read More